These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 26705415)

  • 1. Commentary: By and for clinicians: the early years of Framingham.
    Aronowitz RA
    Int J Epidemiol; 2015 Dec; 44(6):1781-4. PubMed ID: 26705415
    [No Abstract]   [Full Text] [Related]  

  • 2. Commentary: Early Framingham: pioneering enterprise and forerunner of modern thought.
    Labarthe DR
    Int J Epidemiol; 2015 Dec; 44(6):1786-90. PubMed ID: 26705417
    [No Abstract]   [Full Text] [Related]  

  • 3. Commentary: Framingham: a landmark investigation.
    Stamler J
    Int J Epidemiol; 2015 Dec; 44(6):1785-6. PubMed ID: 26705416
    [No Abstract]   [Full Text] [Related]  

  • 4. II. Coronary Heart Disease in the Framingham Study.
    Dawber TR; Moore FE; Mann GV
    Int J Epidemiol; 2015 Dec; 44(6):1767-80. PubMed ID: 26705414
    [No Abstract]   [Full Text] [Related]  

  • 5. The Framingham Heart Study: past, present and future.
    Tsao CW; Vasan RS
    Int J Epidemiol; 2015 Dec; 44(6):1763-6. PubMed ID: 26705413
    [No Abstract]   [Full Text] [Related]  

  • 6. [THE INFLUENCE OF ABDOMINAL OBESITY ON LEFT VENTRICULAR MYOCARDIALREMODELING IN PATIENTS WITH ARTERIAL HYPERTENSION].
    Poteklzin NP; Sarkisov KA; Orlov FA; Alatortseva IA; Starovoitova LM; Drozdova IN
    Klin Med (Mosk); 2015; 93(7):67-70. PubMed ID: 26596063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic implications of left ventricular hypertrophy.
    Vakili BA; Okin PM; Devereux RB
    Am Heart J; 2001 Mar; 141(3):334-41. PubMed ID: 11231428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk issues in renal transplantation: cardiac aspects.
    Parfrey PS; Foley RN; Rigatto C
    Transplant Proc; 1999; 31(1-2):291-3. PubMed ID: 10083112
    [No Abstract]   [Full Text] [Related]  

  • 9. [The prognosis of the disease course in patients with hypertension and coronary failure].
    Iureneev AP; Gerashchenko IuS; Dubov PB
    Ter Arkh; 1994; 66(4):9-11. PubMed ID: 8016741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemiology of the hypertensive heart].
    Middeke M
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S253-6. PubMed ID: 19085801
    [No Abstract]   [Full Text] [Related]  

  • 11. Family history of premature coronary heart disease, child cardio-metabolic risk factors and left ventricular mass.
    Magnussen CG; Dwyer T; Venn A
    Cardiol Young; 2014 Oct; 24(5):938-40. PubMed ID: 24107484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Review of epidemiologic studies in cardiology in Poland].
    Podolec P; Karch I; Pajak A; Kopeć G; Broda G; Drygas W; Rynkiewicz A; Zdrojewski T; Cieśliński A
    Kardiol Pol; 2006 Sep; 64(9):1031-7. PubMed ID: 17054040
    [No Abstract]   [Full Text] [Related]  

  • 13. Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989.
    Mosterd A; D'Agostino RB; Silbershatz H; Sytkowski PA; Kannel WB; Grobbee DE; Levy D
    N Engl J Med; 1999 Apr; 340(16):1221-7. PubMed ID: 10210704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Identification of subjects at high risk of coronary disease in a working population using a prediction model].
    Laurier D; Chau NP
    Arch Mal Coeur Vaiss; 1995 Nov; 88(11):1569-75. PubMed ID: 8745990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population.
    Mancia G; Bombelli M; Facchetti R; Madotto F; Corrao G; Trevano FQ; Giannattasio C; Grassi G; Sega R
    J Hypertens; 2008 Aug; 26(8):1602-11. PubMed ID: 18622239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors in young adults. The lessons from epidemiologic studies of cardiovascular disease--Framingham, Tecumseh, and Evans County.
    Dawber TR
    J Am Coll Health Assoc; 1973 Dec; 22(2):84-95. PubMed ID: 4781447
    [No Abstract]   [Full Text] [Related]  

  • 17. Incident CHD and excess body weight in the US population.
    Flegal KM; Williamson DF
    Obesity (Silver Spring); 2010 Jun; 18(6):1069; author reply 1069-70. PubMed ID: 20502453
    [No Abstract]   [Full Text] [Related]  

  • 18. Left ventricular hypertrophy as a predictor of coronary heart disease mortality and the effect of hypertension.
    Brown DW; Giles WH; Croft JB
    Am Heart J; 2000 Dec; 140(6):848-56. PubMed ID: 11099987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of electrocardiographic left ventricular hypertrophy criteria with left ventricular mass by echocardiogram in obese hypertensive patients.
    da Costa W; Riera AR; Costa Fde A; Bombig MT; de Paola AA; Carvalho AC; Fonseca FH; Luna Filho B; Póvoa R
    J Electrocardiol; 2008; 41(6):724-9. PubMed ID: 18954613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular hypertrophy: a population perspective.
    Mayet J; McG Thom SA
    Eur Heart J; 1999 Mar; 20(6):400-1. PubMed ID: 10213341
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.